Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension | Zendy

Henry R. Black | Zendy; Barry R. Davis | Zendy; Joshua I. Barzilay | Zendy; Chuke Nwachuku | Zendy; Charles Baimbridge | Zendy; Horia Marginean | Zendy; Jackson T. Wright | Zendy; Jan Basile | Zendy; Nathan D. Wong | Zendy; Paul K. Whelton | Zendy; Richard A. Dart | Zendy; Udho Thadani | Zendy

Open Access

Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension

Author(s) -

Henry R. Black,

Barry R. Davis,

Joshua I. Barzilay,

Chuke Nwachuku,

Charles Baimbridge,

Horia Marginean,

Jackson T. Wright,

Jan Basile,

Nathan D. Wong,

Paul K. Whelton,

Richard A. Dart,

Udho Thadani

Publication year - 2008

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc07-1452

Subject(s) - chlorthalidone , lisinopril , metabolic syndrome , amlodipine , medicine , thiazide , diabetes mellitus , ace inhibitor , diuretic , metformin , endocrinology , cardiology , blood pressure , angiotensin converting enzyme

Optimal initial antihypertensive drug therapy in people with the metabolic syndrome is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research